A new review of 21 studies challenges the conventional wisdom that it’s preferable to discontinue statins before and after coronary bypass surgery. The review found that continuing statins reduced complications and lowered the chances of death. (The New York Times)
Jacob Sanchez was a newsletters fellow for the Tribune in 2016. At St. Edward’s University, he studied political science and journalism. Previously, Sanchez was an editorial intern at The Texas Observer,... More by Jacob Sanchez
